A team of Ropes & Gray attorneys advised Par Pharmaceutical Companies Inc., a pharmaceutical company engaged in developing, licensing, manufacturing, marketing, and distributing generic and branded products, in its acquisition of JHP Group Holdings, a pharmaceutical company that acquires, develops, manufactures and sells sterile injectable drugs, from Warburg Pincus for approximately $490 million.
The deal was publicly announced on January 21, 2014.
The Ropes & Gray team was led by private equity partner William Shields and included finance partner Alexander Zeltser.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.